| |
| 
|
| November 18, 2013 | 5:30 PM
| Bulls gather at D Street for 2nd day; Markets up 2%
The BSE Sensex and the Nifty rose over 2% tracking gains in other Asian markets, cheered by the prospect of extended stimulus in the United States and real economic reform in China. The BSE Sensex rose 2.21% and the Nifty was up by 2.19% |
| | |
| |
| Major headlines |
| | | Indian indices
Key benchmark share indices surged on Monday to record their highest single-day gains since October 18 after US Fed plans to continue the stimulus measures raised hopes of further foreign inflows and bold economic reforms unveiled by China boosted investor sentiment.
Indian stock markets had a gap up opening on Monday tracking gains in Asia on encouraging stance from the US Fed plans to continue its monetary stimulus measures coupled with bold economic reforms unveiled by China. Markets kept moving upwards for the entire day and settled on a north route with heavyweights like ITC, RIL, L&T and ICICI Bank leading the upmove.
Meanwhile, UBS downgraded India to "neutral" from "overweight" and upgraded China to "overweight", saying Plenum reforms will likely cause China to outperform Asia ex-Japan for the next few months.
The Sensex rose to an intraday high of 20,868.76 while the 50-share Nifty crossed 6150 mark to hit day's high of 6196.80. Broader markets remained firm with the midcap index up 1.18% and the smallcap index gained 0.96%.
| |
|
INDEX PERFORMANCE |  |
| | |
|
|
|
| MARKET INDICATORS |
| |
|
|
| |
| | |
|
Financial Tech | 181.30
| 19.99 |
| | | | | |
| | | | |
| The Ramco Cements |
165.10 | -1.81
| | | |
|
| |
| | | | | | |
| |
| | | |
| |
| | |
| | | |
| | |
On currency front, the Indian rupee rose by 66 paise to as high as 62.44 to the dollar at the interbank foreign exchange. The rupee led gains among emerging Asian currencies on Monday as investors cut bearish bets on regional units, with the dollar softer amid uncertainty over how long the U.S. Federal Reserve will keep up its policy stimulus.
The Sensex closed at 20,850.74, up by 451.32 points, while the Nifty rose by 132.85 points to close at 6,189.00.
Following are the stocks/sectors which were in news today:
-
Elder Pharmaceuticals jumped 5.29% on reports that French drug maker Sanofi SA is close to acquiring the Mumbai-based pharmaceuticals company.
-
Suzlon Energy surged 9.95% after the company said it will unveil its new offshore turbine, the REpower 6.2M152.3.
-
Reliance Infrastructure rose 3.49% after the company announced the commissioned of its 5th 400 kV double circuit transmission line in Maharashtra through its arm Reliance Power Transmission.
| Market sentiment
The market breadth stood in favor of advances. Of the 2586 stocks traded on the BSE, 1403 (54.25%) rose, 1057 (40.87%) fell and 126 (4.87%) stocks remained unchanged.
| Sectoral & stock screening
All the 13 sectoral indices closed in the green zone. Top Gainers- BSE Capital Goods up by 3.19%, BSE Bankex rose by 3.15%, BSE FMCG surged by 2.52%.
Among 'A' group stocks, top three gainers - Financial Technologies rose by 19.99%, MCX up by 17.46% and Suzlon Energy up by 9.95%. Top three losers - Jet Airways declined by 4.39%, Sun TV down by 2.47% and Ramco Cement fell by 1.81%. |
 | |
| |
|
| |
|
Global signals
US stock index futures poised for a higher opening at the Wall Street on Monday.
European shares steadied near 5-year highs on Monday, propped up by gains at planemaker EADS and hearing aid group Sonova, with investors banking on a broad market rally to the end of 2013.
Asian share markets advanced for a third straight session on Monday cheered both by the prospect of extended stimulus in the United States and real economic reform in China. |
| | |
| Commodity Hit List for 18-11-2013 - Evening session
|
| | Support Levels |
LTP |
Resistance Levels | Action |
| S2 |
S1 | R1 |
R2 | |
Gold Cash USD ($) |
1270.00 |
1280.00 | 1284.50
| 1290.00 |
1300.00 |
Buy Above R1/Sell below S1 | |
Gold MCX Dec |
29850.00 | 30100.00
| 30200.00 |
30300.00 |
30500.00 | Buy Above R1/Sell below S1
| |
Silver Cash USD ($) |
20.30 | 20.50
| 20.62 |
20.77 |
21.00 | Buy Above R1/Sell below S1
| |
Silver MCX Nov | 45500.00
| 45950.00 |
46251.00 |
46600.00 | 47000.00
| Buy Above R1/Sell below S1 |
|
Copper MCX Nov | 433.00
| 436.60 |
438.00 |
440.20 | 443.50
| Buy Above R1/Sell below S1 |
|
Zinc MCX Nov | 115.50
| 116.40 |
116.65 |
117.00 | 118.00
| Buy Above R1/Sell below S1 |
|
Nickel MCX Nov | 848.00
| 857.00 |
861.60 |
865.50 | 872.00
| Buy Above R1/Sell below S1 |
|
Aluminium MCX Nov |
108.50 | 109.40
| 109.75 |
110.00 |
111.00 | Buy Above R1/Sell below S1
| |
Lead MCX Nov | 128.50
| 129.70 |
130.05 |
130.70 | 131.50
| Buy Above R1/Sell below S1 |
|
Crude Oil USD ($) |
92.50 | 93.20
| 93.47 |
93.75 |
94.55 | Buy Above R1/Sell below S1
| |
Crude Oil MCX Nov |
5760.00 | 5811.00
| 5848.00 |
5870.00 |
5920.00 | Buy Above R1/Sell below S1
| |
Natural Gas MCX Nov |
228.00 | 229.80
| 231.40 |
232.20 |
235.00 | Buy Above R1/Sell below S1
| | | | |
| | |
To know more about our products and services, click here.
| | | | |
|  |
Sharekhan Ltd. Regd Add: 10th Floor, Beta Building, Lodha iThink Techno Campus, Off. JVLR, Opp. Kanjurmarg Railway Station, Kanjurmarg (East), Mumbai - 400042, Maharashtra. Tel: 022 - 61150000. Sharekhan Ltd.: SEBI Regn. Nos. BSE-Cash-INB011073351 ; F&O-INF011073351 ; NSE - INB/INF231073330; CD - INE231073330 ; MCX Stock Exchange: INB/INF-261073333 ; CD - INE261073330 ; United Stock Exchange: CD - INE271073350 ; DP-NSDL-IN-DP-NSDL-233-2003 ; CDSL-IN-DP-CDSL-271-2004 ; PMS-INP000000662 ; Mutual Fund-ARN 20669 ; Commodity trading through Sharekhan Commodities Pvt. Ltd.: MCX-10080 ; (MCX/TCM/CORP/0425) ; NCDEX -00132 ; (NCDEX/TCM/CORP/0142) ; NSEL-12790 |
| | | |
| |
"This document has been prepared by Sharekhan Ltd. This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction.
Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is from publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees ("SHAREKHAN and affiliates") are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. We do not represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.
SHAREKHAN & affiliates may have used the information set forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. Any comments or statements made herein are those of the analyst and do not necessarily reflect those of SHAREKHAN."
|
| |
